• DOI:10.1038/ncpendmet0160
Corpus ID: 21104519

Drug Insight: cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women

@article{Colao2006DrugIC,
  title={Drug Insight: cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women},
  author={A. Colao and A. Sarno and E. Guerra and M. Leo and A. Mentone and G. Lombardi},
  journal={Nature Clinical Practice Endocrinology &Metabolism},
  year={2006},
  volume={2},
  pages={200-210}
}

• A. Colao, A. Sarno, +3 authors G. Lombardi
• Published 2006
• Medicine
• Nature Clinical Practice Endocrinology &Metabolism

Prolactinoma is the most frequent pituitary tumor histotype. Men generally have macroadenomas whereas women generally have microadenomas. The major objectives of treating prolactinomas are to suppress excessive hormone secretion and its clinical consequences, to remove the tumor mass while preserving the residual pituitary function, and possibly to prevent disease recurrence or progression. Primary therapy of prolactinomas is based on use of dopamine-receptor agonists. Bromocriptine induces… Expand

View on Nature

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed